Istvan Petak: Excited to introduce Genomate Health to Plug and Play Health community

Istvan Petak shared a post on LinkedIn:

“Hello, Amazing Birmingham, UK, and Amazing Plug and Play. I am excited to introduce Genomate Health to one of the most significant innovation ecosystems in the world with 500+ corporate partners, 250+ investments per year, 60+ offices worldwide, breeding 32 unicorns.

Thank you, Plug and Play Tech Center, Plug and Play Health, and Plug and Play UK, for accepting us in your community and connecting us to leading Pharmaceutical, MedTech, and IT technology corporations and investors in the field with whom we can work together to bring our solution that enables oncologists to fully implement precision oncology for their cancer patients as fast as possible.

We started our journey by focusing on healthcare providers, now, we also want to open up to corporate partners by delivering value and solutions for their needs, accelerating the clinical development of new therapies, and teaming up to solve the most challenging problems in healthcare. I congratulate all the other health tech startups selected to PnP with us.

Thank you, Adam McGuinness and team, Miruna Chipara, Agata Maria Bendik, and Polina S., for organizing yesterday’s fantastic kickoff workshop.

Thank you, Kieran Borrett, Plug and Play UK.

Thank you, the University of Birmingham and West Midlands Health Tech Innovation Accelerator (WMHTIA), for hosting us.

Thank you, STARTUP CREASPHERE powered by Plug and Play and Liam Grover.”

Additional information
Source: Istvan Petak/LinkedIn

Dr. Istvan Petak specialises in precision oncology and molecular pharmacology of targeted therapies. He is the founder and CEO of Genomate Health, Inc. Cambridge, MA, founder and board director of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC).